JACKSONVILLE, FLORIDA — An indictment unsealed Thursday charges Charlie Bernard Griffin III and Ethelbert Chinenye Nwanegbo in connection with a scheme that led to approximately $51 million in fraudulent reimbursements from Medicare, Medicaid, and private insurers. The announcement was made by U.S. Attorney Gregory W. Kehoe.

The indictment includes 31 counts of health care fraud and money laundering against Griffin, while Nwanegbo is named in charges related to money laundering. If convicted, each defendant could receive up to 20 years in prison per count.

Federal authorities are seeking $14,245,474 in forfeiture from Griffin as proceeds of health care fraud, along with $17,807,628.14 in property tied to money laundering. Additionally, the United States is pursuing $8,182,800.17 seized from Griffin’s bank accounts, three real properties, and four vehicles. From Nwanegbo, the government seeks $6,068,540.50 in property involved in money laundering.

According to the indictment, Griffin was the owner of First Coast Community Development (FCCD), a Jacksonville-based pharmacy. He entered into an agreement with a marketing company owned by Jonathan Gholston, under which the company referred individuals to FCCD for HIV post-exposure prophylactic medications.

Marketing representatives from Gholston’s company set up tents and tables in Jacksonville, primarily in low-income neighborhoods, offering free, government-sponsored cellphones to individuals who provided personal information. During this process, the representatives also collected health insurance details, including whether the individual was covered by Medicare, Medicaid, or a private insurer.

The agreement stipulated that FCCD would pay the marketing company $200 for each person referred for HIV medications, but only if a claim submitted on that person’s behalf was paid. The marketing company paid its representatives a set amount, usually $50, for every person who was referred to FCCD for HIV medications, but it paid this amount only if a claim submitted on behalf of the person was paid. The indictment states that compensating marketers per referral based on claim payment constitutes an illegal kickback.

Data collected by the marketing team was transmitted to FCCD and its pharmacist, Albert Chester. Using this information, FCCD generated prescriptions for HIV medications authorized by Rashan Jones, a nurse practitioner who had not examined, spoken to, or evaluated any of the individuals for whom the prescriptions were written.

To ensure that FCCD’s claims for the prescriptions were paid, FCCD falsely and fraudulently used a diagnosis code reflecting that the persons to whom the prescriptions were issued had, or had been exposed to, HIV or a sexually transmitted disease. The false diagnosis was documented in the medical records of the persons who were issued the prescriptions. FCCD then filled the prescriptions, submitted claims to Medicare, Medicaid, or private insurers, and received reimbursement when claims were paid.

The conduct attributed to Griffin and his co-conspirators resulted in the submission of tens of thousands of fraudulent claims, leading to total reimbursements of about $51 million. Griffin is alleged to have received approximately $14 million in proceeds from the scheme.

Jonathan Gholston, Albert Chester, and Rashan Jones were previously charged in separate proceedings and have each agreed to plead guilty. Gholston entered a guilty plea in March 2026 for conspiring to receive kickbacks in exchange for referring Medicare and Medicaid beneficiaries for HIV prophylactic medications. Primary source: oig.hhs.gov